Your browser doesn't support javascript.
loading
Recombinant cucurmosin-based immunotoxin targeting HER-2 with potent in vitro anti-cancer cytotoxicity.
Xiong, Jiani; Zhang, Caiyun; Wu, Shuifa; Gu, Xiaofan; Cai, Yumei; Xu, Chunseng; Chen, Zhou; Sun, Jiancheng; Wu, Xiangxin; You, Xiuhua; Huang, Zhihong; Xie, Jieming.
Afiliação
  • Xiong J; Department of Pharmacology, School of Pharmacy, Fujian Provincial Key Laboratory of Natural Medicine Pharmacology, Fujian Medical University, Fuzhou 350122, China; Department of Oncology, Fujian Medical University Union Hospital, Fuzhou 350001, China.
  • Zhang C; Department of Pharmacology, School of Pharmacy, Fujian Provincial Key Laboratory of Natural Medicine Pharmacology, Fujian Medical University, Fuzhou 350122, China.
  • Wu S; The First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou 362000, China.
  • Gu X; Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, East China Normal University, Shanghai, 200333, China.
  • Cai Y; Department of Pharmacology, School of Pharmacy, Fujian Provincial Key Laboratory of Natural Medicine Pharmacology, Fujian Medical University, Fuzhou 350122, China.
  • Xu C; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou 350001, China.
  • Chen Z; Department of Pharmacology, School of Pharmacy, Fujian Provincial Key Laboratory of Natural Medicine Pharmacology, Fujian Medical University, Fuzhou 350122, China.
  • Sun J; Department of Pharmacology, School of Pharmacy, Fujian Provincial Key Laboratory of Natural Medicine Pharmacology, Fujian Medical University, Fuzhou 350122, China.
  • Wu X; Institute of Laboratory Animal Center, Fujian Medical University, Fuzhou, 350122, China.
  • You X; Department of Laboratory, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
  • Huang Z; Public Technology Service Center, Fujian Meidcal University, Fuzhou 350122, China.
  • Xie J; Department of Pharmacology, School of Pharmacy, Fujian Provincial Key Laboratory of Natural Medicine Pharmacology, Fujian Medical University, Fuzhou 350122, China. Electronic address: jmxie@fjmu.edu.cn.
Biochem Biophys Res Commun ; 513(1): 15-21, 2019 05 21.
Article em En | MEDLINE | ID: mdl-30917887
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteínas de Plantas / Neoplasias da Mama / Receptor ErbB-2 / Trastuzumab / Antineoplásicos Imunológicos Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteínas de Plantas / Neoplasias da Mama / Receptor ErbB-2 / Trastuzumab / Antineoplásicos Imunológicos Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article